Shree Ganesh Remedies' Q1 FY 2026-27 Quarterly Results

Result Summary

• Shree Ganesh Remedies Ltd reported a 55.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a decline of 39.6%.
• Its expenses for the quarter were down by 46.0% QoQ and 33.6% YoY.
• The net profit decreased 82.1% QoQ and decreased 67.5% YoY.
• The earnings per share (EPS) of Shree Ganesh Remedies Ltd stood at 0.87 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Shree Ganesh Remedies Ltd is a company known for its involvement in the pharmaceutical industry, with a focus on manufacturing and supplying various chemical and pharmaceutical products. The company specializes in providing intermediates and Active Pharmaceutical Ingredients (APIs) that are crucial for the pharmaceutical manufacturing process. As of the latest available information, Shree Ganesh Remedies Ltd continues to be a player in the pharmaceutical sector, although specific recent developments or strategic initiatives undertaken by the company are not detailed in the provided data.

Revenue

In Q1FY27, Shree Ganesh Remedies Ltd reported a total income of ₹15.30 crores. This represents a significant decrease of 55.3% compared to the previous quarter, Q4FY26, where total income was ₹34.22 crores. When compared year-over-year with Q1FY26, which had a total income of ₹25.33 crores, there is a decline of 39.6%. The quarter-over-quarter and year-over-year decreases in revenue highlight substantial changes in the company's income generation for the reported periods.

Profitability

The profit before tax for Q1FY27 was ₹1.53 crores, showing a decrease of 82.5% from ₹8.72 crores in Q4FY26. Compared to Q1FY26, where the profit before tax was ₹4.60 crores, there is a year-over-year reduction of 66.7%. The tax expenses in Q1FY27 were ₹0.41 crores, down from ₹2.45 crores in Q4FY26, marking an 83.3% decline, and a 64.3% decrease from ₹1.15 crores in Q1FY26. Profit after tax for Q1FY27 amounted to ₹1.12 crores, which is 82.1% lower than Q4FY26's ₹6.27 crores, and 67.5% lower than the ₹3.45 crores reported in Q1FY26. Earnings per share also reflect these changes, with a decrease to ₹0.87 in Q1FY27 from ₹4.88 in Q4FY26 and ₹2.68 in Q1FY26, representing declines of 82.2% and 67.5% respectively.

Operating Metrics

Total expenses for Q1FY27 were recorded at ₹13.77 crores, compared to ₹25.50 crores in Q4FY26, showing a reduction of 46.0%. When compared to Q1FY26's expenses of ₹20.73 crores, there is a 33.6% decline. These figures indicate a substantial reduction in expenses both quarter-over-quarter and year-over-year. While specific operational efficiencies or changes are not detailed in the available data, the substantial decrease in expenses is a notable aspect of the company's financial operations for the quarter. The provided data does not include specific information on operational metrics such as production volumes or utilization rates, focusing instead on financial outcomes.